FdaApplication
BLA 761071
Identifiers
- fda_app_no: BLA761071
Properties
| Property | Value |
|---|---|
| applicant_name | Sandoz Inc. |
| application_type | BLA |
| approval_date | 2018-10-30 |
Products (10)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYRIMOZ | ADALIMUMAB-ADAZ | 40MG/0.8ML | Injection |
| HYRIMOZ | — | 80MG/0.8ML | Injection |
| HYRIMOZ | — | 10MG/0.1ML | Injection |
| HYRIMOZ | — | 20MG/0.4ML | Injection |
| HYRIMOZ | — | 40MG/0.4ML | Injection |
| HYRIMOZ | — | 40MG/0.8ML | Injection |
| HYRIMOZ | — | 20MG/0.2ML | Injection |
| HYRIMOZ | — | 10MG/0.2ML | Injection |
| HYRIMOZ | — | 40MG/0.4ML | Injection |
| HYRIMOZ | — | 80MG/0.8ML | Injection |
10 products